童颜针独家代理权生变，*ST苏吴医美“救命稻草”不保

新浪证券2025-07-30

*ST苏吴（维权）“救命稻草”不保，韩国Regen公司单方面宣布解除合作，撤销其孙公司达透医疗对“童颜针”AestheFill（艾塑菲）在中国大陆的独家代理权。这对本就挣扎在退市边缘的江苏吴中而言，无异于致命一击。代理权争夺战：爱美客入主引爆“核弹”这场风暴早有预兆。今年3月，医美巨头爱美客（300896.SZ）宣布拟收购Regen控股权——而Regen正是AestheFill的研发方。6月底，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555019800?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-30 16:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555019800","market":"sh","top_or_hot":-1,"title":"童颜针独家代理权生变，*ST苏吴医美“救命稻草”不保","media":"新浪证券","content":"<div>\n<p>*ST苏吴（维权）“救命稻草”不保，韩国Regen公司单方面宣布解除合作，撤销其孙公司达透医疗对“童颜针”AestheFill（艾塑菲）在中国大陆的独家代理权。这对本就挣扎在退市边缘的江苏吴中而言，无异于致命一击。代理权争夺战：爱美客入主引爆“核弹”这场风暴早有预兆。今年3月，医美巨头爱美客（300896.SZ）宣布拟收购Regen控股权——而Regen正是AestheFill的研发方。6月底，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073016224797275a6e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>童颜针独家代理权生变，*ST苏吴医美“救命稻草”不保</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n童颜针独家代理权生变，*ST苏吴医美“救命稻草”不保\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-30 16:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073016224797275a6e&s=b><strong>新浪证券</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>*ST苏吴（维权）“救命稻草”不保，韩国Regen公司单方面宣布解除合作，撤销其孙公司达透医疗对“童颜针”AestheFill（艾塑菲）在中国大陆的独家代理权。这对本就挣扎在退市边缘的江苏吴中而言，无异于致命一击。代理权争夺战：爱美客入主引爆“核弹”这场风暴早有预兆。今年3月，医美巨头爱美客（300896.SZ）宣布拟收购Regen控股权——而Regen正是AestheFill的研发方。6月底，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073016224797275a6e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0012","symbol_name":"证金概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073016224797275a6e&s=b","article_id":"2555019800","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073016224797275a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555019800","pubTimestamp":1753863757,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"*ST苏吴（维权）“救命稻草”不保，韩国Regen公司单方面宣布解除合作，撤销其孙公司达透医疗对“童颜针”AestheFill（艾塑菲）在中国大陆的独家代理权。如今这根“救命稻草”被抽走，江苏吴中直言医美板块下半年营收利润将“大幅下滑”。此次事件可能加剧行业代理商群体的不安全感，若因此降低市场投入力度，将拖累整个医美产业链表现。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600200":"*ST苏吴","BK0012":"证金概念","BK0060":"抗癌","BK0028":"国家队","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"The exclusive agency rights of Tongyan Needles have changed, * ST Suwu Medical Beauty's \"life-saving straw\" is not guaranteed","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600200":1},"content_text":"*ST苏吴（维权）“救命稻草”不保，韩国Regen公司单方面宣布解除合作，撤销其孙公司达透医疗对“童颜针”AestheFill（艾塑菲）在中国大陆的独家代理权。这对本就挣扎在退市边缘的江苏吴中而言，无异于致命一击。代理权争夺战：爱美客入主引爆“核弹”这场风暴早有预兆。今年3月，医美巨头爱美客（300896.SZ）宣布拟收购Regen控股权——而Regen正是AestheFill的研发方。6月底，随着爱美客完成对Regen的控股并改组董事会，达透医疗便收到一纸《解约函》。Regen指控达透医疗违规转让业务至母公司江苏吴中美学，且江苏吴中因财务造假、实控人隐瞒变更等重大违规遭证监会处罚，“严重损害品牌声誉”。生死攸关：一款产品撑起半壁江山对江苏吴中而言，失去AestheFill绝非普通业务调整。数据显示：2024年：AestheFill贡献营收3.26亿元，占总收入20.42%；毛利2.69亿元，占比高达34.80%，助公司净利润暴增197.97%扭亏为盈。2025年一季度：该产品营收占比飙升至35.55%，毛利占比45.77%，已成公司绝对业绩支柱。如今这根“救命稻草”被抽走，江苏吴中直言医美板块下半年营收利润将“大幅下滑”。更严峻的是，公司7月13日刚因财务造假等重大违法收到《行政处罚事先告知书》，退市风险高悬。绝地反击：江苏吴中控诉“恶意违约”面对危机，江苏吴中火力全开反击：法律层面：坚称“未转让代理权”，协议中“无行政处罚触发解约条款”，已启动法律程序维权。舆论层面：通过官微痛斥Regen及爱美客“恶意践踏契约精神”“打压竞争对手”，更指其“黑化中国企业跨国形象”，措辞之激烈近年罕见。行业震荡：代理商模式遭遇灵魂拷问这场争夺战折射出医美代理商模式的深层困境：品牌方始终握有主动权，代理商常陷博弈被动。若想摆脱不确定性，要么转型自有品牌，要么与厂商深度绑定（如合资）。此次事件可能加剧行业代理商群体的不安全感，若因此降低市场投入力度，将拖累整个医美产业链表现。童颜针红海：巨头割据战火升级AestheFill代理权易手的背后，是医美再生材料市场的爆发性增长。2023年中国童颜针市场规模近6亿元，2024年迎来产品上市潮：圣博玛艾维岚、爱美客濡白天使（2021年获批）江苏吴中艾塑菲、塑妍萃、普丽妍（2024年获批）四环医药渼颜空间（2025年7月上市）随着爱美客将AestheFill收入囊中（传其国内新名为“臻爱 塑菲”），其“濡白天使+AestheFill”双王牌组合已形成碾压优势。而失去核心产品的江苏吴中，在退市危机与业务崩塌的双重夹击下，前途愈发凶险。本文结合AI工具生成","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555019800","isCrawlerRequest":true}